FK 633. FR 144633.
D000818:Animals; D002317:Cardiovascular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006224:Cricetinae; D004151:Dipeptides / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D006083:Graft Occlusion, Vascular / Q000188:drug therapy*; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013927:Thrombosis / Q000188:drug therapy*
D002317:Cardiovascular Agents; D004151:Dipeptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; C103087:((4-(4-amidinophenoxy)butanoyl)aspartyl)valine